The clear choice for reducing cardiovascular (CV) risk
Only VASCEPA has the FDA's stamp of approval for reducing CV risk when added to a statin.
Proven by science.
In a landmark clinical trial involving more than 8,000 eligible patients, VASCEPA was proven and FDA-approved to reduce CV risk when added to a statin.
VASCEPA is the only FDA-approved oral medication that can make this bold statement.
Is there anything more important than heart protection? If you or someone you love has heart disease, or had experienced a previous heart attack or stroke, there is no time to waste. VASCEPA is proven to provide 25% additional heart protection when added to a statin.*
*In a clinical study, patients treated with VASCEPA and a statin had fewer CV events (17.2%) compared to those who took placebo (22%).
What’s in VASCEPA?
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of eicosapentaenoic acid (EPA)
How VASCEPA reduces CV risk
VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with high triglycerides (≥150 mg/dL) and heart disease or diabetes with other CV risk factors. The exact science of how VASCEPA works in your body is not fully understood, but years of clinical testing have led to proven results. Ask your doctor about heart protection with VASCEPA.
Fish oil supplements
- After reviewing decades of research, the FDA found fish oil supplements do not meet the standard required for a significant scientific health claim
- Contain a mixture of ingredients that may be harmful to heart health, and may have a pronounced fishy smell or require smell masking to hide the signs of deterioration/oxidation (rotting)
- Not intended or approved to treat heart disease
- The American Heart Association advises against self-medicating with supplements
- The most expensive product is one that doesn't treat the intended condition
- Proven CV benefit in the landmark REDUCE-IT® trial
- Made up of one active ingredient: IPE (icosapent ethyl), an innovative form of EPA
- FDA approved to significantly reduce CV risk in patients taking statins. If you cannot take statins, talk to your doctor about whether or not VASCEPA can help you
- Recognized by medical societies to lower CV risk in patients with heart disease or diabetes and risk factors
When it comes to protecting your heart, the choice is clear: FDA-approved VASCEPA
Talk to your doctor about CV risk reduction
As you discuss with your doctor or pharmacist if VASCEPA may be right for you to reduce your CV risk, the subject of generic alternatives to VASCEPA may come up.
Between insurance coverage, Medicare Part D, and the VASCEPA Savings Card (see offer below), you may find that VASCEPA is actually cheaper than a generic. If you have any questions or concerns about cost, make sure to contact your insurance company.